Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: ShenZhen

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Atosiban is a combined receptor antagonist for oxytocin and vasopressin V1A, which are structurally similar to vasopressin V1A.When oxytocin receptor is blocked, oxytocin can still play its role through V1A receptor. Therefore, both the above two receptor pathways need to be blocked at the same time to effectively inhibit uterine contraction.This is one of the main reasons why beta-agonists, calcium channel blockers, and prostaglandin synthase inhibitors are not effective in suppressing uterine contractions.

Send your message to this supplier
  • From:
  • To:
    Senova Technology Company Limited
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service